Choreo LLC Sells 1,954 Shares of Waters Corporation $WAT

Choreo LLC lessened its holdings in Waters Corporation (NYSE:WAT) by 73.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 720 shares of the medical instruments supplier’s stock after selling 1,954 shares during the period. Choreo LLC’s holdings in Waters were worth $251,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Alliancebernstein L.P. lifted its position in shares of Waters by 15.7% during the first quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock valued at $1,131,757,000 after buying an additional 416,669 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Waters by 93.3% during the first quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock worth $211,125,000 after purchasing an additional 276,433 shares during the period. Nuveen LLC acquired a new stake in Waters during the 1st quarter valued at approximately $94,028,000. Jupiter Asset Management Ltd. lifted its position in Waters by 307.6% during the second quarter. Jupiter Asset Management Ltd. now owns 287,316 shares of the medical instruments supplier’s stock valued at $100,285,000 after purchasing an additional 216,825 shares during the period. Finally, Artisan Partners Limited Partnership boosted its stake in shares of Waters by 121.6% in the second quarter. Artisan Partners Limited Partnership now owns 389,824 shares of the medical instruments supplier’s stock worth $136,064,000 after buying an additional 213,930 shares during the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Price Performance

Shares of NYSE WAT opened at $394.41 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.08 and a current ratio of 1.53. The firm has a fifty day moving average of $360.46 and a 200 day moving average of $332.34. The firm has a market cap of $23.48 billion, a PE ratio of 36.25, a PEG ratio of 3.60 and a beta of 1.16. Waters Corporation has a one year low of $275.05 and a one year high of $423.56.

Waters (NYSE:WAT) last posted its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. As a group, research analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on WAT shares. JPMorgan Chase & Co. lifted their price target on Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Morgan Stanley initiated coverage on shares of Waters in a research note on Monday. They set an “equal weight” rating and a $423.00 price objective on the stock. Rothschild & Co Redburn started coverage on shares of Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price for the company. TD Cowen increased their price target on shares of Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday, November 5th. Finally, Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $384.33.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.